Literature DB >> 20620941

Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways.

Keunwook Lee1, Prathyusha Gudapati, Srdjan Dragovic, Charles Spencer, Sebastian Joyce, Nigel Killeen, Mark A Magnuson, Mark Boothby.   

Abstract

Many functions of the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) have been defined, but relatively little is known about the biology of an alternative mTOR complex, mTORC2. We showed that conditional deletion of rictor, an essential subunit of mTORC2, impaired differentiation into T helper 1 (Th1) and Th2 cells without diversion into FoxP3(+) status or substantial effect on Th17 cell differentiation. mTORC2 promoted phosphorylation of protein kinase B (PKB, or Akt) and PKC, Akt activity, and nuclear NF-kappaB transcription factors in response to T cell activation. Complementation with active Akt restored only T-bet transcription factor expression and Th1 cell differentiation, whereas activated PKC-theta reverted only GATA3 transcription factor and the Th2 cell defect of mTORC2 mutant cells. Collectively, the data uncover vital mTOR-PKC and mTOR-Akt connections in T cell differentiation and reveal distinct pathways by which mTORC2 regulates development of Th1 and Th2 cell subsets. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620941      PMCID: PMC2911434          DOI: 10.1016/j.immuni.2010.06.002

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  58 in total

1.  Protein kinase C theta is expressed in mast cells and is functionally involved in Fcepsilon receptor I signaling.

Authors:  Y Liu; C Graham; V Parravicini; M J Brown; J Rivera; S Shaw
Journal:  J Leukoc Biol       Date:  2001-05       Impact factor: 4.962

2.  PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals.

Authors:  Sang Hoon Ha; Do-Hyung Kim; Il-Shin Kim; Jung Hwan Kim; Mi Nam Lee; Hyun Ju Lee; Jong Heon Kim; Sung Key Jang; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Cell Signal       Date:  2006-06-03       Impact factor: 4.315

3.  Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.

Authors:  David A Guertin; Deanna M Stevens; Carson C Thoreen; Aurora A Burds; Nada Y Kalaany; Jason Moffat; Michael Brown; Kevin J Fitzgerald; David M Sabatini
Journal:  Dev Cell       Date:  2006-12       Impact factor: 12.270

4.  SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.

Authors:  Estela Jacinto; Valeria Facchinetti; Dou Liu; Nelyn Soto; Shiniu Wei; Sung Yun Jung; Qiaojia Huang; Jun Qin; Bing Su
Journal:  Cell       Date:  2006-09-07       Impact factor: 41.582

5.  Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability.

Authors:  Chiyo Shiota; Jeong-Taek Woo; Jill Lindner; Kathy D Shelton; Mark A Magnuson
Journal:  Dev Cell       Date:  2006-09-07       Impact factor: 12.270

6.  TcR and TcR-CD28 engagement of protein kinase B (PKB/AKT) and glycogen synthase kinase-3 (GSK-3) operates independently of guanine nucleotide exchange factor VAV-1.

Authors:  Joanne E Wood; Helga Schneider; Christopher E Rudd
Journal:  J Biol Chem       Date:  2006-08-11       Impact factor: 5.157

7.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

8.  A sensitive assay for the quantification of integrin-mediated adhesiveness of human stem cells and leukocyte subpopulations in whole blood.

Authors:  Mathias H Konstandin; Guido H Wabnitz; Huelya Aksoy; Henning Kirchgessner; Thomas J Dengler; Yvonne Samstag
Journal:  J Immunol Methods       Date:  2007-08-13       Impact factor: 2.303

9.  Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation.

Authors:  Marisa M Juntilla; Jessica A Wofford; Morris J Birnbaum; Jeffrey C Rathmell; Gary A Koretzky
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 11.205

Review 10.  AKT/PKB signaling: navigating downstream.

Authors:  Brendan D Manning; Lewis C Cantley
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

View more
  239 in total

Review 1.  The "other" mTOR complex: New insights into mTORC2 immunobiology and their implications.

Authors:  Helong Dai; Angus W Thomson
Journal:  Am J Transplant       Date:  2019-03-19       Impact factor: 8.086

2.  Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.

Authors:  Kazuhiro Tanaka; Ivan Babic; David Nathanson; David Akhavan; Deliang Guo; Beatrice Gini; Julie Dang; Shaojun Zhu; Huijun Yang; Jason De Jesus; Ali Nael Amzajerdi; Yinan Zhang; Christian C Dibble; Hancai Dan; Amanda Rinkenbaugh; William H Yong; Harry V Vinters; Joseph F Gera; Webster K Cavenee; Timothy F Cloughesy; Brendan D Manning; Albert S Baldwin; Paul S Mischel
Journal:  Cancer Discov       Date:  2011-09-13       Impact factor: 39.397

3.  The liver kinase B1 is a central regulator of T cell development, activation, and metabolism.

Authors:  Nancie J MacIver; Julianna Blagih; Donte C Saucillo; Luciana Tonelli; Takla Griss; Jeffrey C Rathmell; Russell G Jones
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

4.  Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1.

Authors:  Jonathan Brown; Huizhi Wang; Jill Suttles; Dana T Graves; Michael Martin
Journal:  J Biol Chem       Date:  2011-11-01       Impact factor: 5.157

Review 5.  Highlights of the advances in basic immunology in 2011.

Authors:  Juan Liu; Shuxun Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2012-04-23       Impact factor: 11.530

Review 6.  MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.

Authors:  Russell G Jones; Edward J Pearce
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

Review 7.  Rapamycin-resistant effector T-cell therapy.

Authors:  Daniel H Fowler
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

8.  Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation.

Authors:  Hung D Nguyen; Shilpak Chatterjee; Kelley M K Haarberg; Yongxia Wu; David Bastian; Jessica Heinrichs; Jianing Fu; Anusara Daenthanasanmak; Steven Schutt; Sharad Shrestha; Chen Liu; Honglin Wang; Hongbo Chi; Shikhar Mehrotra; Xue-Zhong Yu
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

Review 9.  Induction and stability of the anergic phenotype in T cells.

Authors:  Rut Valdor; Fernando Macian
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

10.  Role of tumor suppressor TSC1 in regulating antigen-specific primary and memory CD8 T cell responses to bacterial infection.

Authors:  Sruti Krishna; Jialong Yang; Hongxia Wang; Yurong Qiu; Xiao-Ping Zhong
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.